<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Corporate &#8211; Phynova</title>
	<atom:link href="https://www.staging.phynova.com/tag/corporate/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.staging.phynova.com</link>
	<description>Harnessing the Therapeutic Power of Plants</description>
	<lastBuildDate>Tue, 02 Nov 2021 11:51:09 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	
	<item>
		<title>DSM Venturing cornerstones €10m funding round</title>
		<link>https://www.staging.phynova.com/dsm-venturing-2020/</link>
		
		<dc:creator><![CDATA[Site Admin]]></dc:creator>
		<pubDate>Mon, 11 May 2020 10:00:04 +0000</pubDate>
				<category><![CDATA[2020]]></category>
		<category><![CDATA[Corporate]]></category>
		<guid isPermaLink="false">https://www.phynova.com/?p=1250</guid>

					<description><![CDATA[DSM Venturing cornerstones €10m funding round as Oxford-based Phynova progresses its blood-glucose Reducose® technology to commercial success. DSM Venturing, part of Royal DSM, a global leader in nutrition, health, and sustainable living, is the cornerstone investor in Oxford-based Phynova’s €10m funding round.  Phynova is working towards fulfilling significant commercial orders for its Reducose® technology in<br/><a href="https://www.staging.phynova.com/dsm-venturing-2020/" class="more">Read more</a>]]></description>
		
		
		
			</item>
		<item>
		<title>Reducose® announces partnership with Liverpool FC</title>
		<link>https://www.staging.phynova.com/reducose-announces-partnership-with-liverpool-fc/</link>
		
		<dc:creator><![CDATA[Site Admin]]></dc:creator>
		<pubDate>Mon, 16 Sep 2019 09:00:09 +0000</pubDate>
				<category><![CDATA[2019]]></category>
		<category><![CDATA[Corporate]]></category>
		<category><![CDATA[Reducose]]></category>
		<guid isPermaLink="false">https://www.phynova.com/?p=1142</guid>

					<description><![CDATA[Phynova has announced its functional food ingredient, Reducose®, has been named as an official regional partner of Liverpool FC in China. Reducose®, which is used to support healthy blood glucose levels, will use the partnership to increase its brand awareness in China. The functional food ingredient, which is now available to consumers in China, is<br/><a href="https://www.staging.phynova.com/reducose-announces-partnership-with-liverpool-fc/" class="more">Read more</a>]]></description>
		
		
		
			</item>
		<item>
		<title>DSM and Phynova reach agreement for global distribution of Reducose®</title>
		<link>https://www.staging.phynova.com/dsm-and-phynova-reach-agreement-for-global-distribution-of-reducose/</link>
		
		<dc:creator><![CDATA[Site Admin]]></dc:creator>
		<pubDate>Tue, 12 Mar 2019 12:00:35 +0000</pubDate>
				<category><![CDATA[2019]]></category>
		<category><![CDATA[Corporate]]></category>
		<category><![CDATA[Reducose]]></category>
		<guid isPermaLink="false">https://www.phynova.com/?p=1106</guid>

					<description><![CDATA[DSM and Phynova reach agreement for global distribution of Reducose®, a science-backed natural ingredient for healthy blood glucose levels DSM and Phynova have signed a global distribution and collaboration agreement for Reducose®, a patented, natural ingredient for healthy blood glucose levels. Reducose® is backed by several clinical studies and it has regulatory approvals in multiple<br/><a href="https://www.staging.phynova.com/dsm-and-phynova-reach-agreement-for-global-distribution-of-reducose/" class="more">Read more</a>]]></description>
		
		
		
			</item>
	</channel>
</rss>
